Active substances
Benserazide + Levodopa
- SFDA 5
- Health Canada 3
- NHS prices 6
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| MADOPAR 250 MG TABS | 200,50 mg,mg | Tablet · Oral use | 30 Blister | SAR 62.80 | NCE · Prescription | ROCHE | Valid |
| MADOPAR 125MG HBS CAPS | 100,25 mg | Capsule, hard · Oral use | 100 Blister | SAR 87.05 | NCE · Prescription | ROCHE | Withdrawn by MAH · Not Marketed |
| MADOPAR 125MG HBS CAPS | 100,25 mg | Capsule, hard · Oral use | 30 Blister | SAR 29.35 | NCE · Prescription | ROCHE | Withdrawn by MAH · Not Marketed |
| MADOPAR 250 MG CAPS | 200,50 mg,mg | Tablet · Oral use | 100 Blister | SAR 186.00 | NCE · Prescription | ROCHE | Withdrawn by MAH · Not Marketed |
| MADOPAR 250 MG TABS | 200,50 mg | Tablet · Oral use | 100 Blister | SAR 186.00 | NCE · Prescription | ROCHE | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
HYPERTENSION; PARKINSONISM
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| PROLOPA CAP 100-25 | 00386464 | 100 MG; 25 MG | CAPSULE · ORAL | HOFFMANN-LA ROCHE LIMITED |
| PROLOPA CAP 200-50 | 00386472 | 200 MG; 50 MG | CAPSULE · ORAL | HOFFMANN-LA ROCHE LIMITED |
| PROLOPA CAP 50-12.5 | 00522597 | 12.5 MG; 50 MG | CAPSULE · ORAL | HOFFMANN-LA ROCHE LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Co-beneldopa 12.5mg/50mg capsules | £13.09 | 100 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Co-beneldopa 12.5mg/50mg dispersible tablets sugar free | £5.90 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Co-beneldopa 25mg/100mg capsules | £6.91 | 100 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Co-beneldopa 25mg/100mg dispersible tablets sugar free | £10.45 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Co-beneldopa 25mg/100mg modified-release capsules | £12.77 | 100 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Co-beneldopa 50mg/200mg capsules | £11.78 | 100 capsule | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 5.1.3. Medicines for parkinsonism · core
Therapeutic equivalent to levodopa + carbidopa for Parkinson disease
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.